Pioneering Clinical Pharmacology & Drug Development.

Pioneering Clinical Pharmacology, Pharmacometrics & Pre-Clinical Safety

Inncelerex specializes in supporting drug development across all stages, including: candidate selection, toxicology, pre-clinical, early clinical development, late-phase clinical trials, drug registration and post marketing requirements.

Our integration of scientific and regulatory expertise in clinical pharmacology, modeling and simulation, translational medicine, toxicology and pre-clinical safety offers comprehensive solutions which serve to enhance program design, execution and strategic decision-making.

Our ability to manage a broad spectrum of studies, including clinical pharmacology, pharmacometrics, pharmacodynamics, toxicology, and ADME studies, ensures program efficiency and precision.

KEY EXPERTISE

DALL·E 2024-02-09 18.41.21 - Create an ultra-minimalist laboratory scene that is nearly em

DALL·E 2024-02-11 10.23.59 - Visualize a highly simplified and minimalist pharmaceutical r

DALL·E 2024-02-11 10.30.03 - Imagine a very minimalist pharmaceutical research lab with a

CLINICAL PHARMACOLOGY

Our extensive experience in clinical pharmacology and early development provides the expertise to design an efficient program and take development candidates from pre-IND through various phases in clinical development.

PHARMACOMETRICS, MODELING & SIMULATION

Our experience in Modeling and Simulation is coupled with clinical pharmacology that provides a seamless solution for clients to save time and cost of development and guide the program at critical decision points.

PRE-CLINICAL SAFETY AND TOXICOLOGY

Broad experience in design, tailoring and overseeing pre-clinical safety investigational and GLP studies to enable INDs, and support entry into clinical phase and the full clinical development.

DALL·E 2024-02-11 10.32.43 - Visualize a simplified and clean genetic research concept_edi

DALL·E 2024-02-13 14.54.24 - Design a refined pharmaceutical infographic with a slightly m

TRANSLATIONAL MEDICINE

We are a team of experienced drug development experts who utilize and maximize gain from any data generated in early in development programs and look for signs and markers that would guide decision-making, program design and endpoint selection.

DRUG DEVELOPMENT & PROGRAM TECHNICAL OVERSIGHT

We expertly design, oversee, and interpret a wide range of studies, including pre-clinical, early and late-phase clinical trials. Our focus areas encompass pharmacokinetics, pharmacodynamics, efficacy, drug interactions, bioequivalence, first-in-human studies, TQT, and renal/hepatic impairment, along with age and gender studies. These expertise extends to Phase 2 and Phase 3 trials as needed.

DRUG DEVELOPMENT & PROGRAM TECHNICAL OVERSIGHT

We expertly design, oversee, and interpret a wide range of studies, including pre-clinical, early, and late phase clinical trials. Our focus areas encompass pharmacokinetics, pharmacodynamics, efficacy, drug interactions, bioequivalence, first in human studies, TQT, and renal/hepatic impairment, along with age and gender studies. This expertise extends to Phase 2 and Phase 3 trials as needed.